Aprea Therapeutics, Inc. Liquidation Value Calculator
Aprea Therapeutics, Inc.
Current Price: N/A
Loading calculator data...
Advanced: All 87 XBRL Tags
Every XBRL tag from SEC EDGAR filings, grouped by financial statement type. total = may include children, fact = independent leaf value.
Balance Sheet
| Tag | Value | Unit | ||
|---|---|---|---|---|
| accounts_payable | ||||
| Accounts Payable Current total AccountsPayableCurrent |
$713,668 | USD | ||
| cash | ||||
| Cash And Cash Equivalents At Carrying Value total CashAndCashEquivalentsAtCarryingValue |
$14.60M | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents total CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents |
$14.64M | USD | ||
| Restricted Cash total RestrictedCash |
$41,186 | USD | ||
| Restricted Cash Noncurrent total RestrictedCashNoncurrent |
$41,186 | USD | ||
| current_liabilities | ||||
| Employee Related Liabilities Current total EmployeeRelatedLiabilitiesCurrent |
$770,562 | USD | ||
| Other Accrued Liabilities Current total OtherAccruedLiabilitiesCurrent |
$161,372 | USD | ||
| liabilities_current | ||||
| Liabilities Current total LiabilitiesCurrent |
$2.76M | USD | ||
| shares_outstanding | ||||
| Common Stock Shares Outstanding total CommonStockSharesOutstanding |
8.2M | shares | ||
Unmapped Tags (76)
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | $94,155 | USD | ||
| Additional Paid In Capital AdditionalPaidInCapital | $356.71M | USD | ||
| Assets Assets | $15.93M | USD | ||
| Assets Current AssetsCurrent | $15.56M | USD | ||
| Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Common Stock Shares Authorized CommonStockSharesAuthorized | $400.00M | shares | ||
| Common Stock Shares Issued CommonStockSharesIssued | $8.19M | shares | ||
| Common Stock Value CommonStockValue | $8,192 | USD | ||
| Deferred Tax Assets Gross DeferredTaxAssetsGross | $56.35M | USD | ||
| Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards | $48.57M | USD | ||
| Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment | $878 | USD | ||
| Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch | $3.39M | USD | ||
| Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance | $56.35M | USD | ||
| Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity | $15.93M | USD | ||
| Other Assets Noncurrent OtherAssetsNoncurrent | $271,162 | USD | ||
| Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Preferred Stock Shares Authorized PreferredStockSharesAuthorized | $40.00M | shares | ||
| Property Plant And Equipment Gross PropertyPlantAndEquipmentGross | $153,962 | USD | ||
| Property Plant And Equipment Net PropertyPlantAndEquipmentNet | $59,807 | USD | ||
| Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit | $-333.64M | USD | ||
| Stockholders Equity StockholdersEquity | $12.44M | USD | ||
| Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount | $6.20M | USD | ||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | $478,141 | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | $-8.25M | USD | ||
| Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | $4.13M | USD | ||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | $4,679 | USD | ||
| Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash | $478,141 | USD | ||
| Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable | $-646,701 | USD | ||
| Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities | $-64,488 | USD | ||
| Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | $217,906 | USD | ||
| Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities | $4.64M | USD | ||
| Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities | $-12.89M | USD | ||
| Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts | $407,459 | USD | ||
| Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock | $5.05M | USD | ||
| Proceeds From Warrant Exercises ProceedsFromWarrantExercises | $91 | USD | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax | $-10.63M | USD | ||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | $5.93M | shares | ||
| Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax | $-12.61M | USD | ||
| Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities | $199,095 | USD | ||
| Earnings Per Share Basic EarningsPerShareBasic | $-2 | USD/shares | ||
| Earnings Per Share Diluted EarningsPerShareDiluted | $-2 | USD/shares | ||
| Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations | $0 | pure | ||
| Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | $0 | pure | ||
| Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | $-0 | pure | ||
| Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense | $-0 | pure | ||
| Effective Income Tax Rate Reconciliation Tax Contingencies Other EffectiveIncomeTaxRateReconciliationTaxContingenciesOther | $-0 | pure | ||
| Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | $-0 | pure | ||
| General And Administrative Expense GeneralAndAdministrativeExpense | $6.48M | USD | ||
| Income Tax Expense Benefit IncomeTaxExpenseBenefit | $0 | USD | ||
| Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | $2.59M | USD | ||
| Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential | $1,024 | USD | ||
| Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | $-2.65M | USD | ||
| Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense | $20,946 | USD | ||
| Income Tax Reconciliation Tax Contingencies Other IncomeTaxReconciliationTaxContingenciesOther | $73,496 | USD | ||
| Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch | $42,220 | USD | ||
| Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet | $652,086 | USD | ||
| Net Income Loss NetIncomeLoss | $-12.60M | USD | ||
| Operating Expenses OperatingExpenses | $13.52M | USD | ||
| Operating Income Loss OperatingIncomeLoss | $-13.23M | USD | ||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax | $-7,335 | USD | ||
| Other Nonoperating Income OtherNonoperatingIncome | $77,500 | USD | ||
| Other Nonoperating Income Expense OtherNonoperatingIncomeExpense | $634,267 | USD | ||
| Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent | $961,899 | USD | ||
| Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost | $7.04M | USD | ||
| Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer | $285,759 | USD | ||
| Accrued Professional Fees Current AccruedProfessionalFeesCurrent | $248,591 | USD | ||
| Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding | $6.89M | shares | ||
| Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1 | $583,702 | USD | ||
| Depreciation Depletion And Amortization DepreciationDepletionAndAmortization | $21,715 | USD | ||
| Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax | $-95,319 | USD | ||
| Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent | $100,000 | USD | ||
| Loss Contingency Accrual Provision LossContingencyAccrualProvision | $0 | USD | ||
| Profit Loss ProfitLoss | $-12.60M | USD | ||
| Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | $583,702 | USD | ||
| Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices | $39,050 | USD | ||
| Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues | $2.72M | USD |
Showing balance sheet tags only. Liquidation analysis uses balance sheet data.